632625-91-3

Upstream product

• 23915-07-3 1-(bromomethyl)-2,4-difluorobenzene 
• 635-93-8 5-chlorosalicyclaldehyde 

Downstream Products

• 1285074-76-1 2-(bromomethyl)-4-chloro-1-((2,4-difluorobenzyl)oxy)benzene 
• 1428130-77-1 1-{5-chloro-2-[(2,4-difluorobenzyl)oxy]benzyl}-5-iodo-1,2,3,4-tetrahydro-1,8-naphthyridine 
• 1428128-01-1 sodium 1-(5-chloro-2-((2,4-difluorobenzyl)oxy)benzyl)indoline-4-carboxylate 
• 1428130-14-6 methyl 1-(5-chloro-2-((2,4-difluorobenzyl)oxy)benzyl)indoline-4-carboxylate 
• 1428127-99-4 sodium 1-(5-chloro-2-((2,4-difluorobenzyl)oxy)benzyl)-1H-pyrrolo[2,3-c]pyridine-4-carboxylate 
• 1428130-12-4 1-(5-chloro-2-((2,4-difluorobenzyl)oxy)benzyl)-1H-pyrrolo[2,3-c]pyridine-4-carboxylic acid 
• 1428130-10-2 1-(5-chloro-2-((2,4-difluorobenzyl)oxy)benzyl)-1H-pyrrolo[2,3-c]pyridine-4-carbonitrile 
• 1428129-62-7 1-{5-chloro-2-[(2,4-difluorobenzyl)oxy]phenyl}methanamine 

Relevant academic research and scientific papers

Ep1 receptor ligands

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation,

EP1 RECEPTOR LIGANDS

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.